Regen BioPharma Inc (RGBP): Operating Cash Flow
-$383.6K
Year ended 2025-09-30
-$445.2K
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$383.6K | n/m | 2025-12-30, From 2024-10-01 |
| 2024-09-30 | -$751.5K | n/m | 2025-12-30, From 2023-10-01 |
| 2023-09-30 | -$173.9K | n/m | 2025-05-13, From 2022-10-01 |
| 2022-09-30 | -$606.9K | n/c | 2023-11-20, From 2021-10-01 |
| 2021-09-30 | -$1.13M | n/m | 2022-11-15, From 2020-10-01 |
| 2020-09-30 | $18.6K | n/m | 2021-12-22, From 2019-10-01 |
| 2019-09-30 | -$481.8K | n/m | 2021-08-04, From 2018-10-01 |
| 2018-09-30 | -$1.58M | n/m | 2021-06-21, From 2017-10-01 |
| 2017-09-30 | -$1.89M | n/m | 2018-12-27, From 2016-10-01 |
| 2016-09-30 | -$1.67M | n/m | 2016-12-21, From 2015-10-01 |
| 2015-09-30 | -$1.19M | n/a | 2016-12-21, From 2014-10-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$383.6K | n/m |
| Clene Inc. (CLNN) | 2025-12-31 | -$18.55M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | -$2.99M | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$3.75M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$14.82M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$15.95M | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$3.33M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$8.95M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$9.81M | n/m |
Compare RGBP, CLNN, ABVC, HIND side by side · Screen every company in Pharmaceutical Preparations ↗